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INTRODUCTION
Primary pituitary carcinomas are very rare neoplasms de-
fined as adenohypophyseal tumors with cerebrospinal and/or
systemic metastasis. They represent approximately 0.2% of
all operated adenohypophyseal neoplasms (1). The disease
was first reported in 1931 by Cairns et al. (2) in a 25-yr-old
woman with pituitary adenoma and intradural spinal cord
metastasis. There have been more than 100 cases of pituitary
carcinoma reported, including functional and nonfunctional
tumors (3), but none in the Korean literature to the best of
our knowledge. The histologic features of pituitary carcino-
mas are vary from typical adenoma to tumor with marked
pleomorphism and frequent mitoses (4, 5). Here we report a
case of pituitary carcinoma with left mandibular metastasis
in a 36-yr-old woman. 
CASE REPORT
A 36-yr-old woman with a 3-week history of headache
was presented at the outpatient otorhinolaryngology clinic
for the evaluation of suspicious sinusitis in November 2005.
Symptoms including nausea, vomiting, myalgia, and gener-
al weakness worsened despite ongoing antibiotic therapy. No
lesion was found in the initial brain computed tomography
(CT) scan. Twenty days later she reported right-side ptosis
and amenorrhea. Magnetic resonance imaging revealed a 2.5-
cm sellar and suprasellar mass with heterogeneous enhance-
ment, and suspicious invasion to both cavernous sinuses and
the left maxillary sinusitis (Fig. 1). The mass compressed the
optic chiasm. Her serum prolactin level was 123.17 ng/mL
before surgery. She underwent gross-total resection based on
the initial diagnosis of pituitary macroadenoma with 3rd
and 6th nerve palsy. Histologically, the resected tumor was
composed of variable-sized nests and single cells mixed with
adenohypophyseal cells, which appeared normal (Fig. 2). The
tumor cells had polygonal vesicular nuclei with marked pleo-
morphism and prominent nucleoli. The cytoplasm was aci-
dophilic and granular (Fig. 3). When presented, mitoses
counted 3 per 10 high power fields (HPFs). Immunohisto-
chemistry staining was strongly positive for prolactin (PRL)
(Fig. 4), but negative for adenocorticotropic hormone (ACTH)
and growth hormone (GH). Immunostaining was also posi-
tive for synaptophysin and p53 (Fig. 5A), but not for cytok-
eratin, vimentin or glial fibrillary acidic protein (GFAP). The
Ki-67 labeling index (Fig. 5B) was high. Postoperative CT
scanning revealed a residual nodular enhancement at the supe-
rior portion of the resected mass. Radiotherapy (total dose
5,040 Gy) was undertaken after surgery, based on the atypi-
cal morphology of the pituitary tumor and the presence of
the residual enhanced mass. The prolactin level fell to 5.17
ng/mL after surgery and adjuvant radiotherapy. 
The patient was readmitted 6 months later with a one-
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Pituitary Carcinoma with Mandibular Metastasis: A Case Report
Pituitary carcinomas are rare primary adenohypophyseal tumors with cerebrospinal
or extracranial metastasis. The present case, the first report of the disease in Korea,
involved a 36-yr-old woman who presented with a 3-week history of headache. Brain
magnetic resonance imaging revealed a 2.5-cm sellar and suprasellar mass show-
ing heterogeneous enhancement with suspicious invasion of both cavernous sinu-
ses. The patient underwent gross-total resection. The tumor cells were composed
of polygonal cells singly or in variable-sized nests. The nuclei were large and round
with prominent nucleoli. The cytoplasms was acidophilic and granular. Marked pleo-
morphism and frequent mitoses (3 per 10 HPFs) were found. By immunohistoche-
mistry, tumor cells were strongly positive for prolactin, but negative for ACTH and
GH. Additional immunostainings for cytokeratin, vimentin, and glial fibrillary acidic
protein (GFAP) were negative. After the surgery, the patient received radiotherapy
because of the atypical histologic features. The prolactin level fell from 123.17 ng/
mL to 5.17 ng/mL after surgery. Nine months after the initial diagnosis, the patient
died from mandibular metastasis associated with the pituitary carcinoma. 
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month history of left cheek and periauricular pain. The pa-
tient had problems opening her mouth, and painful swelling
and local heating. Radiologic assessment revealed a soft tis-
sue mass with cortical destruction and a permeative osteoly-
tic lesion at the left mandibular ramus (Fig. 6). A partial man-
dibulectomy was performed. Grossly, the mandible and per-
imandibular soft tissue were involved by the tumor. The his-
tologic features (Fig. 7) and the immunohistochemical results
were identical to those observed in the previous pituitary
tumor. Primary pituitary carcinoma was confirmed from the
histopathologic findings and a metastasis. She died in August
2006, approximately 9 months after the initial diagnosis. 
Fig. 1. Sagittal contrast enhanced T1-weighted image showing a
lobulating contoured mass (arrow) with heterogeneous enhance-
ment in the sella. Invasion of the posterior wall of the sphenoid
sinus by the sella mass is evident. 
Fig. 2. Resected tumor cells showing variable-sized nests and
single cells (left lower) mixed with adenohypophyseal cells of nor-
mal appearance (right upper) (H&E stain, ×100).
Fig. 3. Tumor cells showing atypical morphology with large round
nuclei and prominent nucleoli. The mitoses are 3/10 high power
fields (H&E, ×400).
Fig. 4. Tumor cells showing strong and diffuse positive staining
for prolactin (Prolactin, ×400).Pituitary Carcinoma with Mandibular Metastasis S147
DISCUSSION
Pituitary carcinomas are rare adenohypophyseal neoplasms
and their definition, diagnosis, therapy, and prognosis are
controversial. Unlike other malignant neoplasms, the diag-
nosis of pituitary carcinoma is based on metastasis and not
on histologic features such as invasion, cellular pleomorph-
ism, nuclear abnormalities, mitotic activity, and necrosis.
More than 100 cases of pituitary carcinoma have been report-
ed worldwide (3), but this is the first report in Korea. 
In a review of the literature on pituitary carcinoma, Per-
nicone et al. (1) reported the endocrinological subtypes in-
clude PRL-producing tumors (30%), ACTH-producing
tumors (28%), GH-producing tumors (10%), thyroid-stim-
ulating hormone-producing tumors (2%), gonodotropin-
producing tumors (2%), and nonfunctioning tumors (26%).
Malignant prolactinomas, such as the case described here,
were the most common (26 cases) subtype of pituitary car-
cinomas reported (6). They predominantly occur in males
(M:F=17:9), in middle age (range: 14-70 yr, mean: 43.6 yr),
and have a poor prognosis. Most of the locations of metasta-
sis are extra/intracranial and spinal sites (50%), but can in-
volve other sites including bones and soft tissues (occiput,
ribs, vertebra, sacroiliac joint, femur, and mandible), and
parenchymal organs (lung, lymph node, liver, ovary, endo-
metrium, and adrenal gland). In addition, nearly all pitu-
itary carcinomas are identified as functioning, mitotically
active, and invasive macroadenomas with a tendency for mul-
tiple metastasis. 
Although the primary pituitary carcinomas have various
histologic features, from monotonous proliferation of cells
with uniform nuclei to cellular pleomorphism and promi-
nent nucleoli, the cytologic atypia does not predict the tumor
behavior. However, there is a slight trend towards a higher
degree of cytologic atypia and increased mitotic activity in
metastasis lesions compared with primary tumors (1). Our
case had atypical morphology with frequent mitoses in both
Fig. 6. Follow-up coronal contrast enhanced T1-weighted image
showing an ill-defined heterogeneously-enhanced soft tissue mass
(arrow) with destruction of the left mandible. Left oropharyngeal
wall-thickening, suggesting spread of the tumor, is also evident. 
Fig. 7. Histopathologic and immunologic features of the metastat-
ic tumor showing similarity to that of the primary pituitary tumor
(H&E stain, ×400).
Fig. 5. (A) Positive immunostaining for p53 in the primary pituitary
tumor (×400). (B) High (10%) Ki-67 labeling index (×400).
A Bprimary and metastasis tumors. The Ki-67 index was high
in the primary and metastasis tumors (10% and 30%, res-
pectively). In the study by Thapar et al. (7), the relationship
between proliferative activity in pituitary adenomas and their
invasiveness was investigated using the MIB-1 monoclonal
antibody, which detects the Ki67 cell cyclespecific nuclear
antigen. The growth fractions of noninvasive adenoma, inva-
sive adenoma, and primary pituitary carcinomas were 1.37±
0.15%, 4.66±0.47%, and 11.91±3.41%, respectively. In
comparison with the above study, the Ki-67 labeling index
in the primary and metastasis lesions of the present case ex-
ceeded the level reported for pituitary carcinomas. In addi-
tion, the p53 immunostaining reported for the tumor sup-
pressor gene was 0%, 15.2%, and 100% for the noninvasive
adenoma, invasive adenoma, and carcinoma, respectively (7).
Our case was p53-positive in both the primary and metasta-
sis pituitary carcinoma. 
Histological changes in pituitary carcinoma after radiation
therapy were reported by Yamashita et al. (8). After irradia-
tion approximately three-fifths of tumor cells were unaltered
and two-fifths showed degeneration. It was suggested the
tumor necrosis after irradiation was not an apoptotic process
but an irradiation effect because TUNEL staining of the nu-
clei of postirradiated cells was negative. However, nonirra-
diated pituitary carcinoma can show extensive necrosis (up
to 50%), as in this case, whether or not apoptosis is involved.
The prognosis of pituitary carcinoma is known to be poor
because of the extent of tumor dissemination at the time of
diagnosis, with the mean survival time reported to be 2 yr
(range 0.25-8 yr) (1). For malignant prolactinomas the latent
period between initial diagnosis and detection of metastases
ranged from 2 to 228 months, and most patients (80%) died
within 18 months of metastasis development. In our case,
the latent period was 6 months, and the patient died 3 months
after metastasis developed. 
In conclusion, pituitary carcinoma is a rare tumor involv-
ing cranio-spinal or systemic metastasis. Irrespective of the
histological morphology, the behavior of primary pituitary
neoplasms cannot be predicted. In view of the poor progno-
sis, atypical morphology including local invasion, increased
mitosis, and a high proliferation index (as in this case), close
follow-up is required for proper management. 
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